Skip to content
OpenCapital
Get started

Rogers Corporation ROG Cash & Equivalents

Cash & Equivalents at other companies

3M logo
3MMMM
$3.73B-41.1%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$35.73M+109%
Biogen logo
BiogenBIIB
$3.38B+30.2%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$41.01M-38.3%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$752M-57.1%
Entegris logo
EntegrisENTG
$442.7M+29.9%

Other financials

Income statement

See full
Revenue$200.5M+5.2%
Gross profit$64.6M+13.3%
Operating income$10.7M+3,667%
Net income$4.5M+421%
EPS (diluted)$0.25+413%

Balance sheet

See full
Total debt$29.8M-10.5%
Total equity$1.2B-6.1%
Total assets$1.4B-5.6%

Cash flow

See full
Operating cash flow$5.8M-50.4%
CapEx$4.7M-51.0%
Free cash flow$1.1M-47.6%

Valuation

See full
Market cap$2.84B+53.1%
Enterprise value$2.67B+57.7%
P/S3.5×+1.2×

Profitability

See full
Gross margin32.2%-0.7pp
Operating margin8.1%-6.7pp
Net margin-7.4%-9.5pp
FCF margin8.5%+1.8pp

Returns & leverage

See full
Return on equity-4.9%-6.3pp
Debt / equity0×0.0×
Current ratio4×+0.1×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Rogers Corporation’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rogers Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rogers Corporation's cash & equivalents?
Rogers Corporation (ROG) reported cash & equivalents of $195.8M in Q1 2026.
How has Rogers Corporation's cash & equivalents changed year-over-year?
Rogers Corporation's cash & equivalents increased by 11.5% year-over-year, from $175.6M to $195.8M.
What is the long-term trend for Rogers Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Rogers Corporation's cash & equivalents has grown at a 0.5% compound annual growth rate (CAGR), from $191.79M to $197M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.